Optical molecular imaging developer ART Advanced Research Technologies reported increased sales of its eXplore Optix molecular imaging system boosted revenue in the third quarter (end-September 30).
Sales at the Saint-Laurent, Quebec-based company increased to $1.1 million in the third quarter, a gain of 48% over $760,000 in the same quarter of 2004. ART also posted a net loss of $3.9 million for the quarter, compared to $2.4 million in the same quarter a year ago.
By AuntMinnie.com staff writers
November 3, 2005
Related Reading
ART launches clinical study, October 24, 2005
SoftScan trial under way, October 7, 2005
ART names Khayat as VP, September 8, 2005
ART cites equivalency with mammo, August 26, 2005
ART revenues up, losses stabilize in Q2, August 4, 2005
Copyright © 2005 AuntMinnie.com
